fda semaglutide shortage resolved february 2025 announcement Novo's Wegovy and Ozempic removed from US list, compounders on notice The End of Compounded Semaglutide:

Stirrett says that a questionnaire is crucial to understand a patients medical history and existing health, as semaglutide may be a high-risk medication for those with medullary thyroid carcinoma and multiple endocrine neoplasia syndrome

Arledge, a plastic surgeon

Review: GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research

GoodLife Meds' partners should maintain certificates of analysis, stability data, and USP compliance documentation

There's just an endless number of tricks that compounders could use," he said in an interview with Reuters

Figure 1 Table 1 Clinical timeline of oral semaglutide-associated depression, antidepressant management, and rechallenge